Milton, MA, United States of America

Nabil El Tayar


Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
3 patents (USPTO):

Title: The Innovative Mind of Nabil El Tayar

Introduction

Nabil El Tayar, an accomplished inventor based in Milton, Massachusetts, has made significant contributions to the field of biotechnology. With a total of three patents to his name, El Tayar is known for his groundbreaking work on protein engineering and therapeutic solutions.

Latest Patents

El Tayar's most recent inventions include the following patents:

1. **Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants** - This invention focuses on a purified polypeptide that corresponds to a mutated form of the soluble LAG-3 protein. This includes fragments comprising the extra-cellular domains D1 and D2, which are crucial for immune regulation.

2. **IFNAR2/IFN complex** - This innovative patent explores the administration of Type I interferon (IFN) as a complex with an interferon binding chain of the human interferon α/β receptor (IFNAR). The complex aims to prolong the in vivo effects of IFN by improving its stability and potency. The design allows for either non-covalent or covalent bonding, enhancing storage conditions and longevity.

Career Highlights

Nabil El Tayar currently works at Applied Research Systems Ars Holding N.V., where his work continues to bridge the gap between innovative research and practical applications in medicine and biotechnology. His contributions have been pivotal in developing treatments that leverage the body's immune response.

Collaborations

Throughout his career, El Tayar has collaborated with notable peers such as Mark Tepper and Bertrand Huard. These partnerships have facilitated the exchange of ideas and expertise, enhancing the innovation landscape within the biotech sphere.

Conclusion

Nabil El Tayar is a remarkable inventor whose work has the potential to change the way we approach immune therapies. With his recent patents, he paves the way for advancements in treatment options that utilize engineered proteins, reinforcing his status as a prominent figure in the field of biotechnology. The impact of his innovations will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…